Armstrong Henry H Associates Inc. reduced its holdings in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 1.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 366,705 shares of the company's stock after selling 6,959 shares during the quarter. Procter & Gamble accounts for 5.5% of Armstrong Henry H Associates Inc.'s holdings, making the stock its 4th biggest position. Armstrong Henry H Associates Inc.'s holdings in Procter & Gamble were worth $58,423,000 as of its most recent SEC filing.
Other institutional investors have also made changes to their positions in the company. Nuveen LLC purchased a new position in Procter & Gamble during the first quarter valued at approximately $1,954,941,000. GAMMA Investing LLC raised its stake in Procter & Gamble by 20,758.5% during the 1st quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock valued at $1,355,087,000 after purchasing an additional 7,913,335 shares during the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of Procter & Gamble by 13.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock valued at $3,660,737,000 after buying an additional 2,466,308 shares in the last quarter. Invesco Ltd. raised its stake in shares of Procter & Gamble by 19.8% in the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock valued at $2,299,580,000 after buying an additional 2,228,151 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of Procter & Gamble by 15.8% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 16,274,563 shares of the company's stock worth $2,728,430,000 after purchasing an additional 2,224,912 shares during the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
PG has been the topic of several recent research reports. BNP Paribas reaffirmed an "outperform" rating and issued a $177.00 target price on shares of Procter & Gamble in a research note on Friday, August 15th. Evercore ISI reiterated an "in-line" rating and issued a $170.00 price objective (down from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. UBS Group set a $180.00 target price on shares of Procter & Gamble and gave the company a "buy" rating in a research note on Wednesday, July 30th. JPMorgan Chase & Co. reissued a "neutral" rating and issued a $170.00 target price (down from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Finally, Barclays set a $164.00 target price on shares of Procter & Gamble and gave the company an "equal weight" rating in a research note on Thursday, July 31st. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $175.12.
Check Out Our Latest Research Report on Procter & Gamble
Insider Activity at Procter & Gamble
In related news, insider Susan Street Whaley sold 1,000 shares of the business's stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $156.84, for a total value of $156,840.00. Following the completion of the transaction, the insider owned 28,436 shares of the company's stock, valued at $4,459,902.24. The trade was a 3.40% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Ma. Fatima Francisco sold 9,100 shares of the business's stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $1,431,157.00. Following the completion of the transaction, the chief executive officer directly owned 27,295 shares of the company's stock, valued at approximately $4,292,684.65. This trade represents a 25.00% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 120,181 shares of company stock valued at $18,918,012. 0.20% of the stock is currently owned by insiders.
Procter & Gamble Trading Down 0.4%
PG stock opened at $158.02 on Friday. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. The company has a fifty day moving average price of $156.21 and a two-hundred day moving average price of $161.84. Procter & Gamble Company has a one year low of $149.91 and a one year high of $180.43. The stock has a market cap of $369.85 billion, a price-to-earnings ratio of 24.27, a price-to-earnings-growth ratio of 4.19 and a beta of 0.36.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping analysts' consensus estimates of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. During the same quarter last year, the firm earned $1.40 earnings per share. The company's revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current year.
Procter & Gamble Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were issued a dividend of $1.0568 per share. The ex-dividend date of this dividend was Friday, July 18th. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.7%. Procter & Gamble's dividend payout ratio (DPR) is currently 64.98%.
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report